The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

Hospitals are testing brain-computer interface technology, which shows promise in helping motor-impaired patients communicate ...

The FDA becomes involved before any new drug molecule is tested in humans. Here’s how upheaval at the agency appears to be affecting specific points in the approval process for new drugs.

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision ... of the review process," a spokesperson ...

Tepylute, a ready-to-dilute thiotepa formulation, approved for breast and ovarian cancers, potentially improving preparation efficiency. Here is a recap of every FDA approval announced by the ...